Phase 1/2 trial of copanlisib in combination with nivolumab for microsatellite stable ( MSS) colorectal cancer (CRC)

被引：0
|
作者：
Christenson, Eric S.
Wala, Jeremiah A.
Parkinson, Rose
Collins, Natalie B.
Jakubowski, Christopher
Lin, Jea-Ren
Wang, Hao
Ho, Won Jin
Chan, Sabrina
Klein, Rachel
Cetasaan, Yvette
Johnson, Emma
Berg, Maureen
Meyerhardt, Jeffrey
Schlechter, Benjamin
Singh, Harshabad
Sorger, Peter K.
Giannakis, Marios
Azad, Nilofer
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT007
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Combination therapy of envafolimab, suvemcitug, and FOLFIRI in patients with metastatic microsatellite stable (MSS) or mismatch-repair proficient (pMMR) colorectal cancer: Results from a phase II clinical trial
    Liu, Y.
    Wang, J.
    Fang, Y.
    Deng, Y.
    Hu, C.
    Fan, Q.
    Gu, K.
    Zhang, Y.
    Yang, C.
    Tian, J.
    Liu, Z.
    Sun, X.
    Sun, S.
    Cheng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S451 - S451
  • [42] Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial
    Bullock, Andrea J.
    Schlechter, Benjamin L.
    Fakih, Marwan G.
    Tsimberidou, Apostolia M.
    Grossman, Joseph E.
    Gordon, Michael S.
    Wilky, Breelyn A.
    Pimentel, Agustin
    Mahadevan, Daruka
    Balmanoukian, Ani S.
    Sanborn, Rachel E.
    Schwartz, Gary K.
    Abou-Alfa, Ghassan K.
    Segal, Neil H.
    Bockorny, Bruno
    Moser, Justin C.
    Sharma, Sunil
    Patel, Jaymin M.
    Wu, Wei
    Chand, Dhan
    Rosenthal, Katherine
    Mednick, Gabriel
    Delepine, Chloe
    Curiel, Tyler J.
    Stebbing, Justin
    Lenz, Heinz-Josef
    O'Day, Steven J.
    El-Khoueiry, Anthony B.
    NATURE MEDICINE, 2024, 30 (09) : 2558 - 2567
  • [43] Humanized patient -derived xenografts (PDXs) recapitulate clinical responses in microsatellite stable (MSS) and unstable (MSI-H) colorectal cancer (CRC)
    Capasso, Anna
    Lang, Julie
    Pitts, Todd M.
    Lieu, Christopher H.
    Kopetz, Scott
    Davis, Sarah L.
    Jordan, Kimberly
    Bagby, Stacey M.
    Messersmith, Wells A.
    Pelanda, Roberta
    Eckhardt, S. Gail
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [44] Durvalumab plus monalizumab, mFOLFOX6, and bevacizumab in patients (pts) with metastatic microsatellite-stable colorectal cancer (MSS-CRC)
    Cho, M.
    Bendell, J. C.
    Han, S-W.
    Naidoo, J.
    Lieu, C.
    Carneiro, B. A.
    Varga, E.
    Li, X.
    Kourtesis, P.
    Abdullah, S. E.
    Patel, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [45] Epigenetic priming prior to pembrolizumab in microsatellite-stable (MSS) advanced colorectal cancer
    Murphy, Adrian Gerard
    White, Sharon
    Walker, Rosalind
    Lutz, Eric R.
    Ahuja, Nita
    Zheng, Lei
    Jaffe, Elizabeth M.
    Azad, Nilofer Saba
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Immune dynamics and response predictors to regorafenib, ipilimumab, and nivolumab (RIN) treatment in chemotherapy resistant microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
    Ye, Jian
    Wang, Chongkai
    Egelston, Colt
    Guo, Weihua
    Lee, Peter
    Fakih, Marwan
    CANCER RESEARCH, 2024, 84 (06)
  • [47] A phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL)
    Saunders, M. P.
    Graham, J.
    Cunningham, D.
    Plummer, R.
    Cook, S.
    Church, D.
    Kerr, R.
    La Thangue, N.
    Kerr, D. J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
    Huyghe, Nicolas
    De Cuyper, Astrid
    Sinapi, Isabelle
    Vempalli, Fazulur Rehaman
    Rinchai, Darawan
    Beyaert, Simon
    Verstraelen, Eleonore
    Goffette, Pierre
    Ghaye, Benoit
    Gilet, Melanie
    Van Maanen, Aline
    Castella, Marie-Laure
    Mlecnik, Bernhard
    Carrasco, Javier
    Galon, Jerome
    Bedognetti, Davide
    Van den Eynde, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] A phase I clinical trial of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant MSS metastatic colorectal cancer (mCRC)
    Fakih, M. G.
    Sandhu, J.
    Lim, D.
    Li, S. M.
    Wang, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S684 - S684
  • [50] Phase II study of durvalumab anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
    Johnson, Benny
    Haymaker, Cara L.
    Parra, Edwin R.
    Soto, Luisa Maren Solis
    Wang, Xuemei
    Thomas, Jane, V
    Dasari, Arvind
    Morris, Van K.
    Raghav, Kanwal
    Vilar, Eduardo
    Kee, Bryan K.
    Eng, Cathy
    Parseghian, Christine M.
    Wolff, Robert A.
    Lee, Younghee
    Lorenzini, Daniele
    Laberiano-Fernandez, Caddie
    Verma, Anuj
    Lang, Wenhua
    Wistuba, Ignacio I.
    Futreal, Andrew
    Kopetz, Scott
    Overman, Michael J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
12345